Gerresheimer has announced a strategic partnership with Milliken & Company to implement LeneX™ UltraGuard®, an advanced additive technology aimed at enhancing polymer performance in pharmaceutical applications. This collaboration builds upon previous successes between Bormioli Pharma S.p.A., a subsidiary of Gerresheimer, and Milliken, showcasing a commitment to high-value solutions for global pharmaceutical clients. By integrating LeneX™ UltraGuard® technology, Gerresheimer aims to meet the rigorous safety, performance, and quality standards required in the pharmaceutical sector, particularly for packaging applications where durability and reliability are paramount.
Roberto Valenti, Material Development Manager at Bormioli Pharma S.p.A., emphasized the dual focus on performance and sustainability, noting that the application of this additive reduces material usage while enhancing packaging capabilities. Ruben Subira, Lead Account Manager at Milliken, highlighted the synergy between materials science and manufacturing expertise, stating that LeneX™ UltraGuard® addresses critical performance needs in demanding environments.
The technology promises up to 40% improved moisture barrier performance in HDPE packaging, allowing for downgauging without sacrificing protective standards. This collaboration not only aligns with sustainability goals by promoting material reduction but also reflects a shared vision between Milliken and Gerresheimer to adapt to evolving market demands. Attendees at the upcoming Interpack trade show in Düsseldorf will have the opportunity to explore these advancements further at Milliken’s booth.
Use the database as your supply chain compass →